Cargando…

Severity and duration of dysglycemia and brain injury among patients with neonatal encephalopathy

BACKGROUND: Evidence is needed to inform thresholds for glycemic management in neonatal encephalopathy (NE). We investigated how severity and duration of dysglycemia relate to brain injury after NE. METHODS: A prospective cohort of 108 neonates ≥36 weeks gestational age with NE were enrolled between...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamino, Daphne, Widjaja, Elysa, Brant, Rollin, Ly, Linh G., Mamak, Eva, Chau, Vann, Moore, Aideen M., Williams, Tricia, Tam, Emily W.Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166778/
https://www.ncbi.nlm.nih.gov/pubmed/37181414
http://dx.doi.org/10.1016/j.eclinm.2023.101914
_version_ 1785038514440634368
author Kamino, Daphne
Widjaja, Elysa
Brant, Rollin
Ly, Linh G.
Mamak, Eva
Chau, Vann
Moore, Aideen M.
Williams, Tricia
Tam, Emily W.Y.
author_facet Kamino, Daphne
Widjaja, Elysa
Brant, Rollin
Ly, Linh G.
Mamak, Eva
Chau, Vann
Moore, Aideen M.
Williams, Tricia
Tam, Emily W.Y.
author_sort Kamino, Daphne
collection PubMed
description BACKGROUND: Evidence is needed to inform thresholds for glycemic management in neonatal encephalopathy (NE). We investigated how severity and duration of dysglycemia relate to brain injury after NE. METHODS: A prospective cohort of 108 neonates ≥36 weeks gestational age with NE were enrolled between August 2014 and November 2019 at the Hospital for Sick Children, in Toronto, Canada. Participants underwent continuous glucose monitoring for 72 h, MRI at day 4 of life, and follow-up at 18 months. Receiver operating characteristic curves were used to assess the predictive value of glucose measures (minimum and maximum glucose, sequential 1 mmol/L glucose thresholds) during the first 72 h of life (HOL) for each brain injury pattern (basal ganglia, watershed, focal infarct, posterior-predominant). Linear and logistic regression analyses were used to assess the relationship between abnormal glycemia and 18-month outcomes (Bayley-III composite scores, Child Behavior Checklist [CBCL] T-scores, neuromotor score, cerebral palsy [CP], death), adjusting for brain injury severity. FINDINGS: Of 108 neonates enrolled, 102 (94%) had an MRI. Maximum glucose during the first 48 HOL best predicted basal ganglia (AUC = 0.811) and watershed (AUC = 0.858) injury. Minimum glucose was not predictive of brain injury (AUC <0.509). Ninety-one (89%) infants underwent follow-up assessments at 19.0 ± 1.7 months. A glucose threshold of >10.1 mmol/L during the first 48 HOL was associated with 5.8-point higher CBCL Internalizing Composite T-score (P = 0.029), 0.3-point worse neuromotor score (P = 0.035), 8.6-fold higher odds for CP diagnosis (P = 0.014). While the glucose threshold of >10.1 mmol/L during the first 48 HOL was associated with higher odds of the composite outcome of severe disability or death (OR 3.0, 95% CI 1.0–8.4, P = 0.042), it was not associated with the composite outcome of moderate-to-severe disability or death (OR 0.9, 95% CI 0.4–2.2, P = 0.801). All associations with outcome lost significance after adjusting for brain injury severity. INTERPRETATION: Maximum glucose concentration in the first 48 HOL is predictive of brain injury after NE. Further trials are needed to assess if protocols to control maximum glucose concentrations improve outcomes after NE. FUNDING: 10.13039/501100000024Canadian Institutes for Health Research, 10.13039/100000002National Institutes of Health, and SickKids Foundation.
format Online
Article
Text
id pubmed-10166778
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-101667782023-05-10 Severity and duration of dysglycemia and brain injury among patients with neonatal encephalopathy Kamino, Daphne Widjaja, Elysa Brant, Rollin Ly, Linh G. Mamak, Eva Chau, Vann Moore, Aideen M. Williams, Tricia Tam, Emily W.Y. eClinicalMedicine Articles BACKGROUND: Evidence is needed to inform thresholds for glycemic management in neonatal encephalopathy (NE). We investigated how severity and duration of dysglycemia relate to brain injury after NE. METHODS: A prospective cohort of 108 neonates ≥36 weeks gestational age with NE were enrolled between August 2014 and November 2019 at the Hospital for Sick Children, in Toronto, Canada. Participants underwent continuous glucose monitoring for 72 h, MRI at day 4 of life, and follow-up at 18 months. Receiver operating characteristic curves were used to assess the predictive value of glucose measures (minimum and maximum glucose, sequential 1 mmol/L glucose thresholds) during the first 72 h of life (HOL) for each brain injury pattern (basal ganglia, watershed, focal infarct, posterior-predominant). Linear and logistic regression analyses were used to assess the relationship between abnormal glycemia and 18-month outcomes (Bayley-III composite scores, Child Behavior Checklist [CBCL] T-scores, neuromotor score, cerebral palsy [CP], death), adjusting for brain injury severity. FINDINGS: Of 108 neonates enrolled, 102 (94%) had an MRI. Maximum glucose during the first 48 HOL best predicted basal ganglia (AUC = 0.811) and watershed (AUC = 0.858) injury. Minimum glucose was not predictive of brain injury (AUC <0.509). Ninety-one (89%) infants underwent follow-up assessments at 19.0 ± 1.7 months. A glucose threshold of >10.1 mmol/L during the first 48 HOL was associated with 5.8-point higher CBCL Internalizing Composite T-score (P = 0.029), 0.3-point worse neuromotor score (P = 0.035), 8.6-fold higher odds for CP diagnosis (P = 0.014). While the glucose threshold of >10.1 mmol/L during the first 48 HOL was associated with higher odds of the composite outcome of severe disability or death (OR 3.0, 95% CI 1.0–8.4, P = 0.042), it was not associated with the composite outcome of moderate-to-severe disability or death (OR 0.9, 95% CI 0.4–2.2, P = 0.801). All associations with outcome lost significance after adjusting for brain injury severity. INTERPRETATION: Maximum glucose concentration in the first 48 HOL is predictive of brain injury after NE. Further trials are needed to assess if protocols to control maximum glucose concentrations improve outcomes after NE. FUNDING: 10.13039/501100000024Canadian Institutes for Health Research, 10.13039/100000002National Institutes of Health, and SickKids Foundation. Elsevier 2023-03-23 /pmc/articles/PMC10166778/ /pubmed/37181414 http://dx.doi.org/10.1016/j.eclinm.2023.101914 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Articles
Kamino, Daphne
Widjaja, Elysa
Brant, Rollin
Ly, Linh G.
Mamak, Eva
Chau, Vann
Moore, Aideen M.
Williams, Tricia
Tam, Emily W.Y.
Severity and duration of dysglycemia and brain injury among patients with neonatal encephalopathy
title Severity and duration of dysglycemia and brain injury among patients with neonatal encephalopathy
title_full Severity and duration of dysglycemia and brain injury among patients with neonatal encephalopathy
title_fullStr Severity and duration of dysglycemia and brain injury among patients with neonatal encephalopathy
title_full_unstemmed Severity and duration of dysglycemia and brain injury among patients with neonatal encephalopathy
title_short Severity and duration of dysglycemia and brain injury among patients with neonatal encephalopathy
title_sort severity and duration of dysglycemia and brain injury among patients with neonatal encephalopathy
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166778/
https://www.ncbi.nlm.nih.gov/pubmed/37181414
http://dx.doi.org/10.1016/j.eclinm.2023.101914
work_keys_str_mv AT kaminodaphne severityanddurationofdysglycemiaandbraininjuryamongpatientswithneonatalencephalopathy
AT widjajaelysa severityanddurationofdysglycemiaandbraininjuryamongpatientswithneonatalencephalopathy
AT brantrollin severityanddurationofdysglycemiaandbraininjuryamongpatientswithneonatalencephalopathy
AT lylinhg severityanddurationofdysglycemiaandbraininjuryamongpatientswithneonatalencephalopathy
AT mamakeva severityanddurationofdysglycemiaandbraininjuryamongpatientswithneonatalencephalopathy
AT chauvann severityanddurationofdysglycemiaandbraininjuryamongpatientswithneonatalencephalopathy
AT mooreaideenm severityanddurationofdysglycemiaandbraininjuryamongpatientswithneonatalencephalopathy
AT williamstricia severityanddurationofdysglycemiaandbraininjuryamongpatientswithneonatalencephalopathy
AT tamemilywy severityanddurationofdysglycemiaandbraininjuryamongpatientswithneonatalencephalopathy